- Home
- FURY vs INO Comparison
FURY vs INO Comparison
Compare FURY & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FURY | INO |
|---|---|---|
| Founded | 2008 | 1979 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.7M | 114.0M |
| IPO Year | 2011 | 1999 |
Fundamental Metrics
Financial Performance| Metric | FURY | INO |
|---|---|---|
| Price | $0.57 | $1.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $1.70 | ★ $6.75 |
| AVG Volume (30 Days) | 346.9K | ★ 3.1M |
| Earning Date | 08-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,220,086.00 |
| Revenue This Year | N/A | $20,156.19 |
| Revenue Next Year | N/A | $421.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $0.36 | $1.03 |
| 52 Week High | $1.02 | $2.86 |
Technical Indicators
Market Signals| Indicator | FURY | INO |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | 36.38 |
| Support Level | $0.51 | $1.03 |
| Resistance Level | $0.64 | $1.23 |
| Average True Range (ATR) | 0.03 | 0.05 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 18.50 | 41.67 |
Price Performance
Historical ComparisonAbout FURY Fury Gold Mines Limited
Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.